Sphere Fluidics is an established life sciences company which has developed unique products for use in single cell analysis and characterisation and provides collaborative R&D services in this area. The company has patented a novel technology platform that enables ultra-high throughput analysis of single cells and generation of their genetic, transcriptomic and proteomic profiles in miniaturised volumes called picodroplets. Sphere Fluidics’ technology enables the study of the mechanism of cell resistance to chemotherapy, isolation of new enzymes and identification of novel microbial molecules created using synthetic biology.